Gilead’s lenacapavir: HIV prospects strongest in long-acting …
WEBAug 25, 2021 · Gilead’s lenacapavir will find its strongest niche as a long-acting HIV combination treatment, experts said. Manasi Vaidya August 25, 2021. Gilead announced a collaboration with Merck in March to study lenacapavir with islatravir, a nucleoside reverse transcriptase translocation inhibitor (NRTTI), which is also a new drug class in HIV.
Home - Clinical Trials Arena
WEBAlio starts trial to expand label for remote monitoring device. The CAVA study is expected to validate the use of SmartPatch technology. More themes. Artificial Intelligence. Cloud. Corporate Governance. Cybersecurity. Environmental Sustainability. Internet of Things.
Biosimilars: top 10 pharma companies leading the way
WEBJan 20, 2022 · Yesterday (19 January), using the same Thematic Research ecosystem, Clinical Trials Arena revealed the top pharma companies best equipped with artificial intelligence. According to our analysis, Novartis, Pfizer, Catalent, Amgen, Biogen, Patheon, Shanghai Henlius Biotech, Viatris, Celltrion, and Samsung Bioepis are …
All Newsletters - Clinical Trials Arena
WEBYour essential pharmaceutical and drug development news, covering new discoveries, research, big pharma trends & deals. Your essential read on industry innovations, from discoveries and R&D to clinical trials, manufacturing, and trends. Your medical device news digest covering respiratory, dental, neurology, cardiovascular, and orthopedic ...
Regulatory Roundup: CytoDyn's Cancer Asset Leronlimab Set to …
WEBDec 6, 2021 · Leronlimab solid tumour trial completed. CytoDyn’s leronlimab for CCR5+ locally advanced or metastatic solid tumours saw its PTSR increase in multiple cancer indications after its Phase II basket trial completed.The trial looked at 22 cancer types, and the largest PTSR changes occurred in glioblastoma multiforme (GBM), throat cancer, and bladder cancer.
EU Clinical Trial Regulation: What You Need to Know
WEBMay 20, 2021 · The way clinical trials are conducted in the EU will undergo a major transformation once the Clinical Trial Regulation comes into effect. The regulation will replace the existing Clinical Trials Directive 2001/20/EC and will harmonise the registration, assessment and supervision processes for clinical trials throughout the EU via the CTIS.
Ozempic (semaglutide) for the Treatment of Type 2 Diabetes
WEBOzempic ® (semaglutide) is a glucagon-like peptide (GLP-1) receptor agonist indicated for the treatment of Type 2 diabetes in adults. The drug was discovered and developed by Novo Nordisk, which submitted a new drug application (NDA) for the drug to the US Food and Drug Administration (FDA) under the Prescription Drug User Fee Act V (PDUFA V ...
Obesity: Six trials to watch over the next 12 months
WEBJun 30, 2023 · According to a report by GlobalData, the market for obesity drugs is predicted to be worth $37.1bn in 2031. GlobalData is a parent company of the Clinical Trials Arena. As more trials take place globally, not only will this help to provide a wider range of treatments for patients but will also assist the unmet need of lack of supply.
Mounjaro (tirzepatide) for the Treatment of Type 2 Diabetes, USA
WEBJun 19, 2024 · Mounjaro ™ (tirzepatide) is a dual-targeted, injectable, sustained-release therapy indicated for the treatment of type 2 diabetes (T2D) in adults as an adjunct to diet and exercise.. Developed by Eli Lilly, a pharmaceutical company based in the US, Mounjaro is the first and only once-weekly glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor ...
9 Essential Components of a Clinical Trial Agreement
WEBJul 28, 2017 · Just like your auto or health insurance policy, sites, CROs and sponsors generally carry clinical trial insurance to protect themselves or the parties involved in a clinical trial. 6. Recordkeeping and Inspection. Generally speaking, the purpose of a clinical trial is to collect safety and effectiveness data on a given medical product.
Skip to content